Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.01 USD | -2.40% | -2.18% | -39.63% |
Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
Apr. 26 | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.63% | 2.26B | |
+40.45% | 2.63B | |
+22.83% | 520M | |
+42.77% | 467M | |
-64.56% | 160M | |
-31.65% | 87.05M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Stephens Adjusts Price Target on Teladoc to $135 From $140, Keeps Equal-Weight Rating